MONTREAL, March 1, 2018 /CNW Telbec/ - Today, the Cancer Research Society launches UpCycle, its new drug repurposingfunding program, which aims at paving a new way toward innovative therapeutic options in the field of cancer. The repurposing of drugs is a proven approach in numerous fields of therapy. It aims for repositioning the use of existing drugs for new applications
The Cancer Research Society is the first organization in Canada seeking to systematically explore and implement the untapped potential of existing medication for the treatment of cancer. Of the roughly 1,500 drugs already approved for treating various human diseases, several have shown themselves able to reduce the risk of developing a particular cancer, halt the progression of tumour cells or reduce the number of relapses. Learn more
"The repositioning of drugs is not new; there are already a number of successes in different fields of research. However, I am convinced that we have seen only the tip of the iceberg with respect to oncology. We are confident we can significantly increase our chances of outsmarting cancer by investing in this type of research," explains Max Fehlmann, President and Chief Executive Officer of the Cancer Research Society.
Canadian researchers who submit the most promising drug repurposing projects will have the opportunity to obtain funding in an amount up to $100,000 to explore and develop their hypotheses. This initial funding will be granted beginning in the fall of 2018. The Society also plans to provide additional support over the next few years to help advance the most impactful projects.
Stay tuned for new developments.
About the Cancer Research Society
Founded in 1945, the Cancer Research Society is the first Canadian organization entirely dedicated to funding research on all types of cancer. Over the course of its history, the Society has supported thousands of our country's best scientific minds who have helped make important strides in the way we prevent, detect, and treat cancer. Thanks to the generosity of its partners and donors across Canada, the Society has distributed more than $140 million in research grants since the year 2000. For more information: CancerResearchSociety.ca
SOURCE Cancer Research Society
Subscribe to our Free Newsletters!
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...
Bronchopulmonary dysplasia or chronic lung disease of infancy is seen in premature and low birth ...
Ear, nose and throat are important organs and disease in one area can affect the others. ENT ...View All